This search was constructed for a thorough, but still routine, literature search. It was not constructed as the basis for a systematic review. Search terms were derived from synonyms and narrower terms in the "artificial intelligence" and "machine learning" trees in EMTREE. I excluded optical character recognition and synonyms from the search as I didn't feel that aspect of artificial intelligence was of interest to my search requester. I removed phrases that contained a shorter phrase that was already present in my search (or attempted to do so).
Friday, August 11, 2023
Artificial intelligence -- keywords and subject headings -- EMBASE
Wednesday, October 19, 2022
Imatinib keywords
(Imatinib* OR 152459-95-5 OR 220127-57-1 OR STI571 OR STI-571 OR ST-1571 OR ST1571 OR CGP57148* OR CGP-57148* OR CGP-57-148B OR CGP-57148 OR CGP57148 OR Agacel OR Albitinib OR Alvotinib OR Celonib OR Clinid OR Datur OR Egitinid OR Fiximab OR Gemfatinib OR Genfatinib OR Gistamel OR Gleevec OR Glemyhib OR Glimatin OR Glitinib OR Glivanib OR Glivec OR Glivon OR Hemator OR Iglib OR Imadat OR Imagerolan OR Imagliv OR Imakrebin OR Imalek OR Imanivec OR Imanix OR Imat OR Imatenil OR Imatib OR Imatinova OR Imatis OR Imavec OR Ingerinib OR Kadir OR Kinacel OR Latib OR Lematech OR Leukovec OR Leutipol OR Leuzek OR Matin OR Matumib OR Maxinib OR Meaxin OR Mesinib OR Mesylonib OR Mitinab OR Mivesta OR Mytib OR Neopax OR Nibarid OR Nibix OR Philachromin OR Radivek OR Redivec OR Ritor OR Sanglee OR Sunmatin OR Survtyk OR Tagonib OR Telux OR Tibaldix OR Timab OR Vativio OR Vek OR Vianib OR XinWei OR Zeite OR Zeite OR Ziatir OR Zoleta)
Sunday, July 3, 2022
Non-malignant disease of an organ
AND the terms below with terms for the organ of interest:
(disease* OR condition* OR disorder* OR pathol* OR syndrom* OR abnormal* OR disturb* OR dysfunction* OR hypofunction* OR function* OR insufficien* OR injur* OR damag* OR failur* OR ischem* OR ischaem* OR necro* OR inflam* OR infect* OR abscess* OR sclero* OR fibro* OR agenesis OR dysgenesis OR anomal* OR atroph* OR hypotroph* OR aplas* OR dysplas* OR metaplas* OR malform* OR deform* OR degenerat* OR cyst* OR edema* OR oedema* OR swelling OR effusion* OR torsion* OR stenos* OR stenotic OR obstruct* OR occlusi* OR ulcer* OR toxicity)
Consider ORing in names for the organ-specific conditions. i.e.
(((organ_term_1 OR organ_term_2 ... OR organ_term_x) AND (disease* OR condition* OR disorder* OR pathol* OR syndrom* OR abnormal* OR disturb* OR dysfunction* OR hypofunction* OR function* OR insufficien* OR injur* OR damag* OR failur* OR ischem* OR ischaem* OR necro* OR inflam* OR infect* OR abscess* OR sclero* OR fibro* OR agenesis OR dysgenesis OR anomal* OR atroph* OR hypotroph* OR aplas* OR dysplas* OR metaplas* OR malform* OR deform* OR degenerat* OR cyst* OR edema* OR oedema* OR swelling OR effusion* OR torsion* OR stenos* OR stenotic OR obstruct* OR occlusi* OR ulcer* OR toxicity)) OR organ_specific_disease_name_1 OR organ_specific_disease_name_2 OR ... organ_specific_disease_name_x)
Use of a proximity operator is preferable to using AND when proxomity searching is available:
(((organ_term_1 OR organ_term_2 ... OR organ_term_x) NEAR/3 (disease* OR condition* OR disorder* OR pathol* OR syndrom* OR abnormal* OR disturb* OR dysfunction* OR hypofunction* OR function* OR insufficien* OR injur* OR damag* OR failur* OR ischem* OR ischaem* OR necro* OR inflam* OR infect* OR abscess* OR sclero* OR fibro* OR agenesis OR dysgenesis OR anomal* OR atroph* OR hypotroph* OR aplas* OR dysplas* OR metaplas* OR malform* OR deform* OR degenerat* OR cyst* OR edema* OR oedema* OR swelling OR effusion* OR torsion* OR stenos* OR stenotic OR obstruct* OR occlusi* OR ulcer* OR toxicity)) OR organ_specific_disease_name_1 OR organ_specific_disease_name_2 OR ... organ_specific_disease_name_x)
Friday, April 1, 2022
Deprescribing
Thursday, October 7, 2021
infliximab - keywords and MeSH
Search terms were harvested gathered from the MeSH and EMTREE thesauri, from the CAS Registry and from Martindale: The Complete Drug Reference
"Infliximab"[Mesh] OR infliximab* OR infliksimab* OR 170277-31-3 OR abp-710 OR abp710 OR avakine OR avsola OR ca2 OR centnf OR flammegis OR flixabi OR gp-1111 OR gp1111 OR inflectra OR ixifi OR pf-06438179 OR pf-6438179 OR pf06438179 OR pf6438179 OR remicade OR remsima OR renflexis OR revellex OR ta-650 OR ta650 OR zessly
Monday, July 19, 2021
Rheumatoid arthritis -- EMBASE
'rheumatoid arthritis'/de OR 'adult onset still disease'/exp OR 'rheumatoid nodule'/exp OR felty*:ab,kw,ti OR 'stills disease':ab,kw,ti OR 'still?s disease':ab,kw,ti OR 'still disease':ab,kw,ti OR beauvais*:ab,kw,ti OR (ra:ab,kw,ti NOT ((((rosmarinic OR 'relative abundance' OR retinoic) NEAR/7 ra):ab,kw,ti) OR 226ra:ab,kw,ti OR '226 ra':ab,kw,ti OR radium:ab,kw,ti)) OR rheumarthrit*:ab,kw,ti OR reumarthrit*:ab,kw,ti OR revmarthrit*:ab,kw,ti OR (((rheumatoid* OR rheumatoid OR reumatoid OR revmatoid OR rheumat* OR reumat* OR revmat*) NEAR/2 (syndrome* OR disease* OR arthriti* OR joint* OR synovi* OR nodul* OR lung* OR vascul*)):ab,kw,ti)
Research instruments - keywords
instrument* OR scale OR scales OR scor* OR index* OR indices OR questionnair* OR survey* OR tool* OR checklist* OR "check list*" OR inventor*
consider including:
measur* OR determination* OR evaluat* OR test OR tests OR "patient-reported outcome*"